YR 3 Management Flashcards
ALCOHOL WITHDRAWAL
o IV vitamin B complex (Pabrinex -prevents progression to Wernicke-Korsakoff)
o Reducing doses of Chlordiazepoxide (reduces symptoms alcohol withdrawal)
o Close attention to dehydration, electrolyte imbalances and infections
o Nutritional support
o Lactulose and phosphate enemas may help any encephalopathy
ANAPHYLAXIS
o ABCDE o High flow Oxygen o IM Adrenaline o IV Chlorpheniramine (antihistamine) o IV Hydrocortisone o IV crystalloid/colloid to maintain blood pressure if hypotensive
ABSCESS
o - Incision and Drainage
o - Antibiotics
CELLULITIS
o If Erysipelas : draw around the lesion, analgesia and Abx
o Medical: oral penicillins (flucloxacillin) or tetracyclines
o Surgical: orbital decompression needed in orbital cellulitis
INFECTIOUS MONONUCLEOSIS
o Bed Rest
o Paracetamol and NSAIDs (for fever and malaise)
o Corticosteroids in severe cases
o NB: do NOT give AMPICLLIN or AMOXICILLIN if infectious mononucleosis is suspected – nearly 100% patients with IM develop a maculopapular rash
o Avoid sport for 2 weeks (risk of splenic rupture)
VARICELLA ZOSTER VIRUS
o Chicken Pox in children: treat symptoms
o Chicken Pox in adults: consider Aciclovir
o Shingles: Aciclovir, valaciclovir, famciclovir
ACUTE ASTHMA
o ABCDE
o Resuscitate
o Monitor O2 sats, ABG and PEFR
o High flow oxygen
o Salbutamol nebulizer (5mg, initially continuously, then 2-4hourly)
o Ipratropium nebulizer (0.5mg, QDS)
o Steroid therapy (100-200mg IV hydrocortisone, followed by 40mg oral prednisolone for 5-7 days)
o If no improvement IV magnesium sulphate
o Consider IV aminophylline
o Consider IV salbutamol
o NB: normal PCO2 is a BAD SIGN in a patient having an asthma attack (patient is fatiguing and can’t blow off CO2)
o Treat underlying cause (e.g. infection)
o Give Antibiotics if underlying infection
o Monitor electrolytes closely because bronchodilators and aminophylline cause a drop in K+
o Discharge when:
- PEF >75% predicted
- Diurnal variation <25%
- Inhaler technique checked
- Stable on discharge medication for 24hours
- Patient owns a PEF meter
- Patient has steroid and bronchodilator therapy
- Arrange follow-up
CHRONIC ASTHMA
o STEP 1
Inhaled SABA as needed
o STEP 2
1st line: low dose (400mcg/day) ICS + SABA as needed
2nd line: leukotriene receptor anatagonist (LRTA) + SABA as needed
o STEP 3
1st line: low dose ICS + LABA + SABA as needed
1st line: medium dose (800mcg/day) ICS + SABA
2nd line: low dose ICS + LRTA + SABA as needed
o STEP 4
1st line: medium dose ICS + LABA (or tiotropium) + SABA as needed
2nd line: medium ICS + LRTA + SABA as needed
o STEP 5
1st line: high dose (2000mcg/day) ICS + LABA (or tiotropium) + immunomodulator + SABA as needed
o STEP 6
1st line: oral corticosteroids + high dose ICS + LABA (or tiotropium) + immunomodulator + SABA as needed
BRONCHIECSTASIS
o Treat acute exacerbations with TWO IV antibiotics, which cover Pseudomonas Aeruginosa (Aminoglycosides, Quinolones)
o Prophylactic Abx in patients with frequent exacerbations
o Inhaled corticosteroids (e.g. fluticasone) reduces inflammation and volume of sputum but doesn’t affect freq. exacerbations
o Bronchodilators
o Maintain hydration
o Flu Vaccination
o Physiotherapy (sputum and mucus clearance to reduce exacerbations)
o Bronchial artery embolization (if life-threatening haemoptysis)
o Surgical: localized resection, lung or heart-lung transplantation
COPD
o Stop smoking
o Bronchodilators:
SABA (salbutamol)
Anticholinergics (ipratropium bromide)
LABA (if >2 exacerbations a year)
o Steroids:
Inhaled beclomethasone in all patients with FEV1 <50% of predicted or >2 exacerbations per year
Regular oral steroids should be avoided
o Pulmonary rehabilitation
o Oxygen therapy
Only if stopped smoking
If PaO2 <7.3kPa on air during a period of clinical stability
PaO2: 7.3-8kPa and signs of secondary polycythaemia, nocturnal hypoxaemia, peripheral oedema or pulmonary HTN
o ACUTE exacerbation:
24% O2 via a venturi mask
Increase slowly in no hypercapnia and still hypoxic (do an ABG)
Corticosteroids
Start empirical Abx therapy if evidence of infection
Respiratory physiotherapy to clear sputum
Non-invasive ventilation in severe cases
o Prevent exacerbations with pneumococcal and influenza vaccination
PNEUMONIA
o Empirical antibiotics
- 0 markers: Oral amoxicillin
- 1 marker: Oral/IV Amoxicillin + Erythromycin
- >1: IV Cefuroxime/Cefortaxime/Co-amoxiclav + Erythromycin
- Add metronidazole if: aspiration, lung abscess, empyema
- Switch to appropriate Abx based on sensitivity
(CAP)Legionella
• Fluoroquinolones (ciprofloxacin) and macrolide (clarithromycin)
(CAP)Mycoplasma pneumonia
• Macrolides (clarithromycin)
(CAP) Chlamydophilia Pneumoniae:
• Doxyclcine or Clarithromycin
(HAP) S.Aureus
• Flucloxacillin +- Vifampicin, vancomycin for MRSA
(HAP) Pseudomonas Aeruginosa
• Piptazobactam or ciprofloxacin +- gentamicin IV
o Supportive treatment: oxygen, IV fluids, CPAP, BiPAP or ITU care for respiratory failure
o For atypical, give a macrolide
TENSION PNEUMOTHORAX
o Maximum O2
o Insert large bore needle into 2nd IC space MCL
o Up to 2.5L of air can be aspirated
o Stop if patient coughs or resistance is felt
o Follow up CXR 2hrs and 2 weeks later
PRIMARY & PT <50YRS:
- <2cm: oxygen and discharge
- > 2cm aspiration, and IC drain if unsuccessful
SECONDARY OR PT>50
- > 2cm: IC drain (aspirate if still >1cm)
- 1-2 cm: aspiration
- <1cm : high flow oxygen
RECURRENT PNEUMOTHORACES
- Chemical pleurodesis (fusing of visceral and parietal pleura with tetracycline)
- Surgical pleurectomy
PULMONARY EMBOLISM
o Haemodynamically stable: - O2 - Anticoagulation with heparin or LMWH - Switch to oral warfarin for at least 3 months (maintain INR 2-3) - Analgesia o Haemodynamically unstable: - Resuscitate - O2 - IV fluids - Thrombolysis with tPA may be considered if cardiac arrest is imminent o Surgical/Radiological: Embolectomy IVC filters
ATRIAL FIBRILLATION
o Rhythm Control
-If >48hrs since onset of AF, anticoagulate for 3-4 weeks before attempting cardioversion
-If <48hrs since onset of AF,
• DC cardioversion
• Chemical (flecainide or amiodarone if IHD)
-Prophylaxis against AF : Sotalol, Amiodarone, Flecainide
o Rate Control (Chronic AF)
Control ventricular rate with digoxin, verapamil and beta-blockers
Aim for ventricular rate -90bmp
o Stroke risk Stratification (CHADS-Vasc)
-Low Risk patients managed with aspirin
-High Risk patients require anticoagulation with warfarin
-RFs : previous thromboembolic event, >75yrs, HTN, DM, CVD, HF, impaired left ventricular function
CARDIAC ARREST
o Safety, ABCDE
o Advanced Life Support
Attack Cardiac monitor and defibrillator
If pulseless ventricular tachycardia or ventricular fibrillation (shockable rhythms)
• Defibrillate once (150-360 J biphasic, 360 J monophasic)
• Resume CPR for 2mins & reassess rhythm and shock again if still pulseless VT or VF
• Administer adrenaline (1mg IV) after second defibrillation and again every 3-5mins
• If shockable rhythm persists after 3rd shock – administer amiodarone 300mg IV
If PEA of asystole
• CPR for 2, then reassess rhythm
• Administer adrenaline (Img IV) every 3-5mins
• Atropine (3mg IV, once only) if asystole or PEA with rate <60bpm
During CPR:
• Check electrodes, paddle positions and contacts
• Secure airway
o Once secure, give continuous compressions and breaths
• Consider Mg, bicarbonate and external pacing
• Stop CPR and check pulse only if change in rhythm or signs of life
o Treatment of reversible causes:
-Hypothermia: warm slowly
-Hypokalaemia and Hyperkalaemia: correct electrolyte levels
-Hypovolaemia: IV colloids, crystalloids and blood products
-Tamponade: pericardiocentesis or chest drain
-Tension pneumothorax: aspiration or chest drain
-Thromboembolism: treat as PE or MI
-Toxins: use antidote for given toxin
ACUTE LEFT VENTRICULAR FAILURE
o Treat Cardiogenic shock
(Severe cardiac failure with low BP)
Managed in ITU by using inotropes (e.g. dobutamine)
o Treating pulmonary oedema
-Sit the patient up
-60-100% oxygen (and consider CPAP)
-Diamorphine ( venodilator +anxiolytic)
-GTN infusion (venodilator reduced preload)
-IV furosemide (venodilator and later diuretic effect)
-Monitor BP, RR, O2 sats, urine output, ECG
-Treat the Cause !
If the patient is worsening: further dose of furosemide, consider CPAP (improves ventilation by recruiting more alveoli, driving fluid out of alveolar spaces and into vasculature. Increase nitrate infusion without dropping systolic BP <100.
CHRONIC LEFT VENTRICULAR FAILURE
o Treat the cause ! (e.g. hypertension)
o Treat exacerbating factors (e.g. anaemia)
o ACE inhibitors (Inhibits RAS and inhibits adverse cardiac remodelling, slows down progression of HF to improve survival)
o Beta-Blockers (Blocks the effects of a chronically activated sympathetic system. Slows the progression of HF and improves survival )
o Loop Diuretics
- Alongside dietary salt restriction, can correct fluid overload
o Aldosterone Antagonist
- Improves survival in patients with NYHA class III/IV symptoms on standard therapy
Monitor K+ (drugs cause hyperkalaemia)
o Angiotensin Receptor Blockers
- May be added in patients with persistent symptoms despite the use of ACE inhibitors and beta-blockers (monitor K+ again)
o Hydalazine and a Nitrate
May be added in patients (particularly Afro-Caribbeans) with persistent symptoms despite the use of ACE inhibitors with beta-blockers
o Digoxin
- Positive inotrope
o Cardiac resynchronization therapy
Biventricular pacing improves symptoms and survival in patients with a left ventricular ejection fraction <35% , cardiac dyssynchrony (QRS >120msec) and moderate-severe symptoms
DEEP VEIN THROMBOSIS
o Anticoagulation
-Heparin whilst waiting for warfarin to increase INR to the target range of 2-3
-DVTs that don’t extend above the knee may be observed and anticoagulated for 3 months
-DVTs extending beyond the knee require anticoagulation for 6 months
-Recurrent DVTs require long-term warfarin
o IVC filter
-Used if anticoagulation is contraindicated and there is risk of embolization
o Prevention
-Graduated compression stockings
-Mobilization
-Prophlyactic heparin
HEART BLOCK
o Chronic:
-Permanent pacemaker recommended in complete heart block, advanced Mobitz type II, symptomatic Mobitz type I
o Acute:
-If associated with clinical deterioration use IV atropine , and consider temporary pacemaker
HYPERTENSION
o Conservative
-Stop smoking, lose weight, reduce alcohol, reduce dietary sodium
o Ix secondary causes
o Medical – treatment recommended if systolic >160mmHg and/or diastolic >100mmHg, or if evidence of end-organ damage.
o Stage 1: Clinic BP >140/90mmHg and subsequent ABPM or HBPM >135/85
o Stage 2: Clinic BP >160/90 and subsequent ABPM or HBPM>150/95
o Severe (stage 3): Clinic SBP>180 or clinic DBP>110
ACE inhibitors/ARBs are first line if
• <55yrs
• Diabetic
• Heart Failure
• Left ventricular dysfunction
CCBs are first line if:
• >55yrs
• Afro-Caribbean
• Thiazide diuretics can be used if CCBs not tolerated
o 2nd line:
Combine ACEi/ARB with CCB
o 3rd line:
Combine ACEi/ARB with CCB plus thiazide like diuretic
o 4th line
ACEi/ARB + CCB + thiazide like diuretic +
• Further diuretic
• OR alpha-blocker
o (may be used in patients with prostate disease)
• OR beta-blocker
o May be considered in younger patients or in patients with AF
o Target BP
Non-diabetic: <140/90mmHg
Diabetes without proteinuria: <130/80mmHg
Diabetes WITH proteinuria: <125/75mmHg
o Acute Malignant Hypertension Management
-IV beta-blocker (e.g. esmolol)
-Labetolol
-Hydralazine sodium nitroprusside
* NB avoid rapid lowering of BP, it can cause cerebral infarction because the autoregulatory mechanisms within the brain for regulating blood flow cause vasoconstriction of the vessels . Lowering rapidly would mean they don’t adapt.
INFECTIVE ENDOCARDITIS
o Antibiotics for 4-6weeks o On clinical suspicion = empirical treatment with benzylpenicillin and gentamicin o Streptococci- continue same as above o Staphylococci: flucloxacillin/vancomycin gentamicin o Enterococci: Ampicillin Gentamicin o Culture negative: Vacomycin Gentamicin o Surgery: urgent valve replacement may be needed if there is a poor response to Abx
STABLE ANGINA
o Minimize cardiac risk factors (BP, hyperlipidaemia, DM)
-All pts should receive aspirin 75mg/day unless contraindicated
o Immediate symptom relief (e.g. GTN spray)
o Long-term management
Beta-blockers
• Contraindicated in : Acute HF, cardiogenic shock, bradycardia, heart block, asthma
-Calcium Channel Blockers
-Nitrates
o Percutaneous Coronary Intervention (PCI)
Performed in patients with stable angina despite maximal tolerable medical therapy
o Coronary Artery bypass graft (CABG)
Occurs in more severe cases (e.g. three-vessel disease)
UNSTABLE ANGINA/NSTEMI
o Admit to coronary care unit
o Oxygen, IV access, monitor vital signs and serial ECG
o GTN
o Morphine (with metoclopramide to counteract nausea)
o Aspirin (300mg initially, followed by 75mg for at least a year if troponin positive or high risk)
If stratified by GRACE score to be intermediate to high risk, continue: (if not , maintain conservative strategy)
o LMWH (e.g. fondaparinux)
o Clopidogrel (300mg initially, followed by 75mg for at least a year if troponin positive or high risk)
o. IV nitrate (e.g.GTN)
o Beta-blocker (e.g. bisprolol)
STEMI
- Attach ECG monitor and IV access
- 300mg Aspirin
- 300mg Clopidogrel (or 180mg Ticagrelor)
- 5-10mg IV Morphine + anti-emetic (e.g. metoclopramide)
- If confirmed STEMI on ECG, and PCI is available within 120 mins: perform primary PCI
- If not, consider fibrinolysis
•Rescue PCI may be performed if continued chest pain or ST elevation after thrombolysis
•STEMI patients and high-risk NSTEMI patients (harm-dynamically unstable) should receive immediate angiography +- PCI.
• CABH considered in patients with 3 vessel disease
-Secondary Prevention
• Anticoagulate with fondaparinux until discharge
• Dual antiplatelet therapy for a year (aspirin + clopidogrel)
• Beta blockers
• ACEi
• Statins (high dose atorvastatin)
• Control risk factors (stop smoking, manage diet and exercise)
-Advice
• No driving for 1 month following MI
-CABG
• Considered in patients with left main stem or three-vessel disease
PERICARDITIS
o Acute -Cardiac tamponade is treated with emergency pericardiocentesis o Medical -Treat underlying cause -NSAIDs for pain and fever relief o Recurrent -Low-dose steroids -Immunosuppressants -Colchicine o Surgical -Pericardiectomy performed in cases of constrictive pericarditis
SVT
o If haemodynamically UNSTABLE:
-Synchronized DC cardioversion
o If haemodynamically STABLE Vagal & Chemical Cardioversion
-Vagal manoeuvres (e.g. Valsalva, carotid massage)
• Carotid massage could dislodge atherosclerotic plaques, so is only performed in young patients
If vagal manoeuvres fail
• 6mg bolus of Adenosine (2nd time increase to 12mg)
o Contraindicated in ASTHMA as it can cause bronchospasm . If so give verapamil 2.5-5mg
o Alternatives: atenolol, amiodarone
o If unresponsive to chemical cardioversion or tachycardia >250bpm or adverse signs (low BP, HF, low consciousness)
• Sedate and synchronized DC cardioversion
• OR IV amiodarone , OR IV digoxin, OR IV beta-blocker
o Ongoing management of SVT:
AVNRT
• Radiofrequency ablation of slow pathway
• Beta-blockers
• Alternatives: feicanide, propafenone, verapamil
AVRT
• Radiofrequency ablation
Sinus Tachycardia
• Exclude secondary cause (e.g. hyperthyroidism)
• Beta-blocker or rate-limiting CCB
VARICOSE VEINS
o Conservative
-Exercise- improves skeletal muscle pump
-Elevation of legs at rest
-Support stockings
o Venous Telangiectasia and Reticular Veins
-Laser sclerotherapy
-Microinjection sclerotherapy
o Surgical
-Saphenofemoral ligation
-Stripping of the long saphenous vein (don’t damage the short because high risk of damaging the sural nerve)
-Avulsion of varicosities
VENOUS ULCER
o Graduated compression (reduced venous stasis)
NOTE: must exclude diabetes, neuropathy and PVD before this is attempted
o Debridement and cleaning
o Antibiotics- if infected
o Topical steroids – may help with surrounding dermatitis
VENTRICULAR FIBRILLATION
o ! Urgent defibrillation and cardioversion
o Patients who survive need full assessment of left ventricular function, myocardial perfusion and electrophysiological stability
o Most survivors will need an implantable cardioverter defibrillator (ICD)
o Empirical beta-blockers
o Some patients may be treated with radiofrequency ablation (RFA)
VENTRICULAR TACHYCARDIA
o ABC approach
o Check if the patient has a PULSE
o Pulseless: follow advanced life support algorithm
o Unstable VT – reduced cardiac output
NB: VF and pulseless VT require defibrillation (unsychronised), but other VTs can be treated with synchronized cardioversion
Correct electrolyte abnormalities
Amiodarone
o Stable VT
-These patients DON’T experience symptoms of haemodynamic compromise
-Correct electrolyte abnormalities
-Amiodarone
-Synchronised DC shock (if above steps are unsuccessful)
o Implantable Cardioverter Defibrillator (ICD)
-ICD is considered if:
• Sustained VT causing syncope
• Sustained VT with ejection fraction <35%
• Previous cardiac arrest due to VT or VF
• MI complicated by non-sustained VT
FIBROADENOMA
Observation and reassurance, but if in doubt refer for USS +- FNA. Surgical excision if large
BREAST ABSCESS
o Antibiotics
o US guided FNA
o Surgical incision and drainage
MASTITIS (can lead to a breast abscess)
o Encourage breast feeding in general, but NOT from the affected breast
o Analgesia
o Antibiotics (Dicloxacillin or Cephalexin- usually caused by Staph Aureus)
o Open incision or percutaneous drainage if abscess
ACROMEGALY
o Surgical
Trans-sphenoidal hypophysectomy is the only curative treatment
o Radiotherapy
Adjunctive to surgery
o Medical – if surgery contraindicated or refused
-Subcutaneous somatostatin analogues
-E.g. ocreteotide, lanreotide
-SEs: abdo pain, steatorrhoea, glucose intolerance, gallstones
o Oral Dopamine Agonists
-E.g. bromocriptine, cabergoline
SEs: nausea, vomiting, constipation, postural hypotension , psychosis
o GH antagonist (pegvisomant)
o Monitor
GH and IGF-1 levels can be used to monitor disease control
ADDISONIAN CRISIS
o Rapid IV fluid rehydration (0.9% saline, IL over 30-60mins, 2-4L in 12-24h)
o 50ml of 50% dextrose to correct hypoglycaemia
o IV 200mg hydrocortisone bolus followed by 100mg 6hourly (until BP is stable)
o Treat the precipitating cause (e.g. Abx for infection)
o Monitor temp, pulse, RR, BP, sat 02 and urine output
ADRENAL INSUFFICIENCY
o Lifelong replacement of:
Glucocorticoids with hydrocortisone. (3/day)
Mineralocorticoids with fludrocortisone
o Hydrocortisone dose needs to be increased during times of acute illness or stress
o If patient also has hypothyroidism, give hydrocortisone BEFORE thyroxine (to prevent precipitating an Addisonian crisis)
o Advice:
-Have a steroid warning card
-Wear a medic-alert bracelet
-Emergency hydrocortisone on hand
CUSHING SYNDROME
o If iatrogenic – discontinue steroids, use lower dose or use a steroid-sparing agent
o Medical
oUsed pre-operatively or if unfit for surgery
oInhibit cortisol synthesis with metyrapone or ketoconazole
oTreat osteoporosis
Physio for muscle weakness
o Surgical
oPituitary Adenomas – trans-sphenoidal adenoma resection
oAdrenal adenoma/carcinoma – surgical removal of tumour
oEctopic ACTH- treatment directed at the tumour
o Radiotherapy
oPerformed in those who aren’t cured and have persistent high cortisol after trans-sphenoidal resection of the tumour
o Bilateral adrenalectomy may be performed in refractory Cushing’s disease
DIABETES INSIPIDUS
o Treat the CAUSE
o Cranial DI
-Give vasopressin analogue (desmopressin)
-If mild – chlorpropamide or carbamazepine can be used to potentiate the residual effects of any residual vasopressin
o Nephrogenic DI
-Sodium and/or protein restriction helps with polyuria
-Thiazide diuretics
DIABETES MELLITUS TYPE 1
o Glycaemic control
-Advice and patient education
• Short-acting insulin (3 times daily before meals)
o Lispro
o Aspart
o Glulisine
• Long-acting insulin (once daily)
o Isophane
o Glargine
o Detemir
-Insulin pumps
-DAFNE courses (dose adjustment for normal eating)
-Monitor
• Regular capillary blood glucose tests
• HbA1c every 3-6months
-Screening and management of complications
-Treatment of hypoglycaemia
• If reduced consciousness: 50ml of 50% glucose IV OR 1mg glucagon IM
• If conscious and cooperative: 50mg oral glucose + starchy snack
o In terms of counselling a patient
-If you’re hypo before a meal, then you have given too much short-acting insulin at the previous meal
-If you’re hypo in the morning, your long-acting is too high (so measure long acting efficacy first thing in the morning)
DKA
Consider HDU/ICU input, central line, arterial line and urinary catheter if severe acidosis, hypotensive or oliguric
- 50 units soluble insulin in 50mL normal 0.9% saline
(Use an insulin sliding scale )
Continue until:
• Capillary ketones <0.3
• Venous pH >7.3
• Venous bicarbonate >18mmol/L
-From this point, change to SC insulin
-Don’t stop the insulin infusion after 1-2 hours after the SC insulin has restarted
-FLUIDS: 500mL normal saline over 15-30mins until SBP>100mmHg. IV dextrose is started in conjunction with 0.9% saline when blood glucose reaches 15mmol/L
-Potassium replacement (because insulin drives potassium into cells)
-Monitor blood glucose, capillary ketones and urine output hourly
-Monitor U&;Es and venous blood gas
-Broad spectrum Abx if infection is suspected
-Thromboprophylaxis
-NBM for at least 6hrs
-NG tube if GCS is reduced
TYPE 2 DIABETES MELLITUS
o Glycaemic control HbA1c above goal at Dx: lifestyle (cardiovascular risk reduction)+ metformin If HbA1c above goal on metformin: • 1st line: o Metformin + lifestyle + SGLT2 inhibitor (empaglifolozin) OR GLP-1 agonist (liraglutide) OR DDP-4 inhibitor (sitagliptin) OR sulphonylurea (glimepiride) OR basal insulin (insulin glargine) • 2nd line: o Metformin + lifestyle + Alpha-glucosidase inhibitor (acarbose) OR thiazolidinedione (pioglitazone) If HbA1c is above goal on metformin + either basal insulin or second non-insulin agent: • 1st line : o Individualized augmented regimen + continued CVD risk reduction/lifestyle Usually 3-drug combination, with metformin as a basis) o Switch to basal-bolus insulin + continued CVD risk reduction • 2nd line: o Bariatric surgery
o Screening for complications
-Retinopathy
-Nephropathy
-Vascular disease
-Diabetic Foot
-Cardiovascular risk factors (recommended in all patients at initial diagnosis)
• Blood pressure management
o First line: thiazide and/or ACEi/ARB and/or CCB
• Lipid management
o Atorvastatin
o Pregnancy – requires strict glycaemic control and planning of conception (BMJ: diet + basal-bolus insulin)